ATLASVivos Therapeutics (VVOS) earnings date: Nov 18, 2026
Vivos Therapeutics (VVOS) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 18, 2026. Analysts expect EPS of -$0.30.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on VVOS
| Last price | $0.11 (-6.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.8% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Vivos Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Vivos Therapeutics reports on Nov 18, 2026. One email the day before, with ATLAS’s read on Vivos Therapeutics. You can switch it off at any time.
Alert me before VVOS reportsFree to start. Creating an account takes under a minute.
VVOS earnings at a glance
| Next report (confirmed) | Wed, Nov 18, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.30 |
| Last report | Aug 14, 2026 · Beat |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +19.4% |
| Average move around a report | ±8.3% (last 4) |
| Sector | Healthcare · Medical Devices |
Vivos Therapeutics earnings history: last 4 reports
Vivos Therapeutics last reported on Aug 14, 2026: EPS of -$0.31 against an estimate of -$0.39 (+20.5% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$0.39 | -$0.31 | +20.5% | Beat | -1.3% |
| May 20, 2026 | -$0.45 | -$0.52 | -15.6% | Miss | 0.0% |
| Apr 15, 2026 | -$0.48 | -$0.58 | -20.8% | Miss | -19.3% |
| Feb 6, 2026 | $3.18 | $6.15 | +93.4% | Beat | +12.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for VVOS
See the fair value, the probability range and the earnings history of Vivos Therapeutics on its ATLAS page.
Vivos Therapeutics (VVOS) stock analysisPlans from €3.99 a month.
Vivos Therapeutics earnings: frequently asked questions
When does Vivos Therapeutics (VVOS) report earnings?
Vivos Therapeutics is scheduled to report on Wednesday, November 18, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for VVOS?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.30 per share (USD). Estimates can change before the report.
How often does VVOS beat earnings estimates?
Of its last 4 reports with a recorded result, Vivos Therapeutics beat the EPS estimate 2 times; the average surprise was +19.4%. Past results do not predict the next one.
How much does VVOS move around earnings?
Over its last 4 reports the stock moved an average of 8.3% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did Vivos Therapeutics beat earnings estimates last quarter?
Vivos Therapeutics last reported on Aug 14, 2026: EPS of -$0.31 against an estimate of -$0.39 (+20.5% surprise), a beat.
How much does VVOS usually move in a day?
On a normal trading day the ATLAS model puts VVOS’s one-day range at about ±4.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 18, 2026
Educational information, not investment advice. Disclaimer